Trametinib Exhibits Potent Pan-Antiviral Activity Against Multiple Flaviviruses in Human Cell Lines

The emergence and re-emergence of flaviviruses such as Zika virus (ZIKV), dengue virus (DENV), and yellow fever virus (YFV) continue to threaten global health, particularly in endemic regions like Brazil. With no licensed antiviral therapies available for these infections, the search for effective treatments remains a priority. This study evaluates the antiviral potential of trametinib, a clinically approved MEK inhibitor, against Brazilian strains of ZIKV, DENV2, DENV3, and the YFV 17DD vaccine strain in human cell lines. Trametinib was selected due to its established safety profile in oncology patients and its ability to inhibit the MEK/ERK signaling pathway—a host cascade hijacked by multiple viruses during replication.

Cytotoxicity assays were conducted in both BHK-21 and Vero cells using crystal violet staining after 24- and 48-hour exposures. Results revealed that trametinib exhibited minimal toxicity at concentrations up to 20 µM in Vero cells, with a CC50 exceeding 170 µM, indicating a high therapeutic window.59-05-2 Formula In contrast, bosutinib showed significant cytotoxicity even at low doses, limiting its utility. Antiviral efficacy was assessed via plaque assay following infection with ZIKV PE-243 (MOI 0.1), DENV2 PI59, DENV3 MG20, or YFV 17DD. Cells were treated with increasing concentrations of trametinib (5–40 µM) for 24 hours post-infection. Notably, trametinib reduced viral titers by over 1,000-fold for ZIKV and nearly 100-fold for DENV2, DENV3, and YFV at optimal concentrations. These effects were dose-dependent and statistically significant (p < 0.001). Importantly, trametinib also demonstrated activity against the ZIKV African MR766 strain, reducing viral titers by 10-fold, confirming its broad-spectrum potential.HOXD10 Antibody Description No direct virucidal activity was observed when viruses were pre-incubated with trametinib, suggesting that the compound acts intracellularly by disrupting viral replication processes rather than destroying viral particles. The EC50 values for ZIKV, DENV2, DENV3, and YFV were consistently low—ranging from 2.46 to 6.33 µM—while the SI values exceeded 50, highlighting a favorable balance between potency and safety. Compared to other inhibitors tested—including selumetinib, saracatinib, and bosutinib—trametinib displayed superior efficacy and tolerability.PMID:34687746

Mechanistically, this antiviral effect is likely linked to the inhibition of ERK phosphorylation, which plays a crucial role in regulating cellular processes essential for flavivirus propagation, including viral RNA synthesis, protein translation, and assembly. Previous studies have shown that MEK/ERK activation is induced by DENV and YFV infection, and its blockade impairs viral yield in both cell culture and animal models. Trametinib’s ability to disrupt these pathways may explain its pan-antiviral activity. Furthermore, prior reports indicate that trametinib reduces HIV infectivity by interfering with capsid uncoating and inhibits influenza virus spread by blocking nuclear export of viral ribonucleoproteins—mechanisms consistent with disruption of ERK-dependent trafficking.

Given that trametinib is already FDA-approved for BRAF-mutated melanoma, its repurposing for flavivirus treatment could be expedited through clinical trials. Its strong performance across multiple flaviviruses, combined with an excellent safety margin, positions it as a leading candidate for broad-spectrum antiviral therapy. Future research should focus on validating these findings in primary human cells and in vivo models, as well as exploring combination therapies to enhance antiviral efficacy and prevent resistance. This work underscores the value of targeting host factors in antiviral drug development and provides compelling evidence for trametinib’s potential as a frontline therapeutic against emerging and re-emerging flaviviral diseases.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

Hydrogen-bonded supramolecular elastomers have emerged as a cornerstone in the development of next-generation wearable electronic devices, offering a unique combination of mechanical robustness, electrical functionality, and autonomous self-repair capability. These materials leverage dynamic, reversible hydrogen bonding interactions—particularly those involving multiple hydrogen-bonding units such as ureidopyrimidinone (UPy), acylsemicarbazide (ASC), and thiourea—to form highly tunable, reconfigurable networks that can rapidly recover after mechanical damage. The ability to self-heal without external intervention or additional healing agents makes them ideal candidates for long-term, reliable operation in flexible and stretchable electronics. This article explores the molecular design principles behind these elastomers, their integration into functional devices, and their transformative role in advancing wearable technologies.

The foundation of these materials lies in the strategic placement of hydrogen-bonding motifs within polymer architectures. When incorporated at chain ends, sidechains, mainchains, or branched sites, these units enable controlled phase separation between hard (hydrogen-bonded) and soft (elastomeric) domains. This microphase-separated morphology imparts both high toughness and excellent elasticity. For example, UPy-functionalized polyurethanes exhibit tensile strengths over 40 MPa and elongation at break exceeding 500%, while maintaining full recovery after cutting and healing. The strength arises from the cooperative nature of quadruple hydrogen bonds, which provide association constants up to 10⁷ M⁻¹, creating a dense, reversible network capable of withstanding significant mechanical stress.

One of the most compelling applications is in self-healing electronic skins (e-skins).Fos B Antibody MedChemExpress These devices mimic human skin by combining sensing, actuation, and self-repair functions. By embedding conductive fillers such as silver nanowires or carbon nanotubes into a hydrogen-bonded matrix, researchers have developed e-skins capable of detecting pressure, strain, temperature, and even subtle biological signals like facial movements and vocal cord vibrations. A key breakthrough came with the development of transparent, room-temperature self-healing films based on PPGTD-IDA—a supramolecular elastomer featuring dynamic hydrogen bonding and metal-ligand coordination. After being cut, these films restored electrical conductivity within seconds, enabling real-time operation of LED circuits and sensor arrays even after repeated damage.

Self-healing conductive films also play a critical role in stretchable interconnects and energy-harvesting systems. In one notable case, a conductive network composed of carbon nanotubes was embedded in a self-healing polyurethane matrix. Upon damage, the film recovered its conductivity fully after 12 hours due to the rapid reformation of hydrogen-bonded crosslinks. Similarly, stretchable triboelectric nanogenerators (TENGs) fabricated using hydrogen-bonded polymers demonstrated nearly 100% recovery of output voltage and current after healing, even under extreme deformation.GFAP Antibody manufacturer These TENGs are particularly valuable for powering wearable sensors through body motion, making them ideal for continuous health monitoring.PMID:35130623

Another major application is in soft actuators designed for robotics and biomedical devices. Inspired by natural muscle systems, these actuators utilize hydrogen-bonded supramolecular networks that respond rapidly to stimuli such as near-infrared (NIR) light. For instance, a biomimetic actuator based on UPy-crosslinked polyurethane achieved bending angles exceeding 90° in under 2 seconds and exhibited a remarkable 99.5% actuating performance recovery after damage. The healing process occurred autonomously at room temperature, allowing the device to function seamlessly after puncturing or cutting. Such capabilities open new possibilities for artificial muscles, wearable rehabilitation devices, and adaptive prosthetics.

Beyond electronics, hydrogen-bonded elastomers are being explored in bio-integrated systems. Dopamine-functionalized elastomers show strong adhesion to biological tissues and have been used to fabricate self-healing bio-electrodes for electromyography (EMG) monitoring. After being cut, these electrodes regained signal integrity within hours, preserving high signal-to-noise ratios and enabling continuous physiological tracking. Additionally, self-healing binders based on SHP-PEG (self-healing poly(ethylene glycol)) have been successfully applied in lithium-ion batteries, where they maintain electrode integrity during volume changes associated with charge-discharge cycles, significantly improving cycle life and Coulombic efficiency.

Despite these advances, challenges remain. Healing efficiency often degrades after multiple cycles due to environmental contamination, such as moisture or dust particles interfering with hydrogen bond formation. Furthermore, many systems still require heat or pressure to initiate healing, limiting their use in ambient conditions. Future research must focus on designing truly autonomous, stimulus-free healing systems—possibly through hierarchical molecular architectures or responsive nanostructures that trigger repair upon damage.

In conclusion, hydrogen-bonded supramolecular elastomers represent a transformative class of materials for wearable electronics. Their ability to combine flexibility, durability, and self-repairability enables the creation of intelligent, resilient, and long-lasting devices. As molecular design becomes more sophisticated and healing mechanisms more autonomous, we anticipate widespread adoption in healthcare, robotics, human-machine interfaces, and sustainable energy systems. The future of wearable technology lies not only in smarter electronics but in materials that can heal themselves—just like living tissue—ushering in an era of truly adaptive, self-sustaining devices.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

The rational design of single atom catalysts (SACs) with tailored electronic and geometric structures is essential for optimizing electrocatalytic performance in carbon dioxide reduction reactions (CO2RR). In this work, we report a highly effective strategy to engineer the atomic-scale environment of copper atoms on MXene supports through selective etching of quaternary MAX phases. The synthesis involves the controlled removal of aluminum from Ti3(Al1−xCux)C2 via molten ZnCl2 treatment at 600 °C, where AlCl3 sublimates selectively, leaving behind isolated Cu atoms anchored onto the Ti3C2Clx surface. This process not only preserves the structural integrity of the MXene but also ensures uniform dispersion of Cu atoms without aggregation.

Advanced characterization techniques confirm the successful formation of single atom Cu sites. Aberration-corrected high-angle annular dark-field scanning transmission electron microscopy (HAADF-STEM) reveals numerous bright dots corresponding to individual Cu atoms distributed across the MXene layers. X-ray absorption near-edge structure (XANES) analysis shows that Cu exhibits an intermediate oxidation state between Cu⁺ and Cu²⁺, indicating charge transfer from Cu to the surrounding oxygen ligands. Extended X-ray absorption fine structure (EXAFS) fitting confirms three-coordinate O–Cu bonding with a bond length of 1.92 Å, with no evidence of Cu–Cu scattering, proving the absence of clustering.

Surface-sensitive techniques such as X-ray photoelectron spectroscopy (XPS) further support these findings. The Cu 2p₃/₂ peak appears at 933.7 eV, consistent with Cu⁺ species stabilized by oxygen coordination. O 1s spectra show contributions from Ti–O and surface hydroxyl groups, confirming the presence of oxygen-rich functionalization on the MXene surface.HLA-F Antibody supplier The Ti 2p and Cl 2p spectra indicate the retention of dominant surface Cl termination, which enhances the stability of the MXene framework under electrochemical conditions.137234-62-9 Formula

Electrocatalytic evaluation demonstrates that SA-Cu-MXene achieves a Faradaic efficiency of 59.1% for methanol production at −1.4 V vs RHE, among the highest reported for SACs in CO2RR.PMID:34319926 The current density reaches 21.3 mA cm⁻² under identical conditions, significantly higher than that of Cu-particles-MXene (9.6 mA cm⁻²) and pristine MXene (3.7 mA cm⁻²). Chronoamperometry tests over a range of potentials reveal a volcano-shaped trend in methanol selectivity, peaking at −1.4 V. Notably, the catalyst maintains >58% Faradaic efficiency after 30 hours of operation, highlighting its robustness.

DFT calculations elucidate the origin of enhanced activity. The Cu–O₃ configuration creates a highly unsaturated electronic structure that facilitates the adsorption and activation of CO2 molecules. The rate-determining step—conversion of HCOOH* to CHO*—is thermodynamically favorable due to a low energy barrier (0.15 eV), attributed to the optimized binding strength of key intermediates. In contrast, nanoparticle Cu surfaces exhibit higher barriers (0.27 eV), leading to less efficient methanol formation. Moreover, the suppression of C–C coupling pathways due to isolated Cu sites favors the selective production of CH3OH over ethylene or ethanol.

This study establishes a clear correlation between atomic-scale structure and catalytic function in SACs. By combining selective etching with precise control over surface chemistry, we demonstrate a powerful approach to engineering single metal atom catalysts with superior activity, selectivity, and stability. The methodology can be extended to other transition metals and layered materials, offering broad potential for next-generation electrocatalysts in renewable energy conversion.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

The adsorption kinetics of benzo[a]pyrene (BaP) on granular activated carbon (GAC), biochar, and Haplic Chernozem soil were investigated to elucidate the underlying mechanisms governing contaminant retention in environmental systems. Batch kinetic experiments revealed a rapid initial uptake of BaP within the first 60 minutes, during which 77–81% of the total adsorption occurred. This fast phase was attributed to the availability of high-energy surface sites and facile diffusion into macro- and mesopores of the sorbents. Subsequently, the adsorption rate slowed significantly, with only 19–23% of additional BaP being captured over the next hour, indicating the onset of intraparticle diffusion limitations.

This biphasic behavior aligns with established models of porous adsorbent dynamics. The initial stage is dominated by physical interactions such as van der Waals forces and π–π stacking between the aromatic rings of BaP and the graphitic surfaces of GAC and biochar. These interactions are particularly strong due to the high electron density in the carbon matrix, facilitating stable binding of planar polyarene molecules. As the external surface becomes saturated, the slower second phase involves the migration of BaP into narrow micropores (diameter < 2 nm), where access is restricted by steric hindrance and reduced mobility. The presence of polar functional groups on biochar may further influence this process through hydrogen bonding or dipole interactions, although these effects were secondary compared to hydrophobic and π–π interactions. Scanning electron microscopy (SEM) imaging confirmed distinct morphological differences among the materials. GAC displayed a heterogeneous structure with rhombohedral fragments and sieve-like pores, while biochar exhibited elongated cylindrical cavities aligned along the original axis of sunflower husk particles. These features support the observed kinetic patterns: the larger pore volume in biochar facilitated faster initial uptake, whereas the high microporosity of GAC enhanced long-term retention.ATG5 Antibody Technical Information Additionally, laser scanning confocal microscopy revealed that the integral surface area of biochar exceeded that of GAC, despite its lower BET surface area, highlighting the significance of macroporous architecture in enhancing mass transfer.59-05-2 supplier

The influence of solvent composition was also critical.PMID:34772541 Acetonitrile, used to dissolve BaP, affected adsorption efficiency by altering the solvation shell around BaP molecules. At low concentrations, acetonitrile improved BaP availability for adsorption; however, higher levels suppressed sorption due to competitive solvation and increased polarity of the liquid phase. Notably, the distribution coefficient (Kd) for BaP showed a positive correlation with acetonitrile content in GAC and biochar systems, especially at a 0.5:20 solid-to-liquid ratio. In contrast, soil exhibited minimal sensitivity to solvent changes, reflecting its lower affinity and limited porosity.

These results confirm that the interaction mechanisms between BaP and sorbents are governed by both thermodynamic equilibrium and kinetic constraints. While the Freundlich model adequately described the isotherms due to surface heterogeneity, the kinetic data highlight the importance of pore hierarchy and molecular transport dynamics. Ultimately, the superior performance of carbonaceous sorbents stems from their tailored microstructure—combining high surface area, optimal pore size distribution, and favorable surface chemistry—which enables efficient capture and stabilization of persistent organic pollutants like BaP.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

The expression of programmed death-ligand 1 (PD-L1) in breast cancer is tightly regulated by a complex interplay of genetic, epigenetic, and signaling pathways that influence both tumor-intrinsic and immune-mediated mechanisms. While PD-L1 was initially considered a passive marker of immune evasion, it is now recognized as a dynamically regulated molecule whose levels are shaped by intrinsic oncogenic signals and extrinsic immune stimuli. In breast cancer, particularly in aggressive subtypes such as triple-negative breast cancer (TNBC), aberrant PD-L1 expression contributes to immune suppression and resistance to therapy, making it a compelling therapeutic target.

One of the most well-documented mechanisms driving PD-L1 upregulation is genomic amplification at the 9p24.1 locus, which harbors the PD-L1 (CD274) gene along with PD-L2 and JAK2. This amplicon is enriched in TNBC and HER2-positive tumors and leads to constitutive activation of JAK-STAT signaling, resulting in sustained PD-L1 expression. Notably, PD-L1 protein overexpression does not always correlate with gene amplification, indicating that post-transcriptional and translational regulation also play critical roles. For instance, enhanced mRNA stability via alterations in the 3’-untranslated region (3’-UTR) has been observed in several cancers, including breast cancer, where disruptions in regulatory elements lead to increased PD-L1 translation.

Epigenetic modifications represent another key layer of PD-L1 regulation. Hypomethylation of the PD-L1 promoter has been documented in TNBC cell lines and patient-derived tissues, leading to increased transcriptional activity. Studies have further shown that global DNA hypomethylation in breast cancer patients correlates with elevated PD-L1 expression in peripheral blood and tumor samples. Additionally, histone modifications—including acetylation and trimethylation—modulate chromatin accessibility at the PD-L1 locus. For example, inhibition of histone deacetylases (HDACs) enhances PD-L1 expression, suggesting a potential mechanism for combining HDAC inhibitors with immune checkpoint blockade.

Several oncogenic signaling pathways converge on PD-L1 transcription. The PI3K/AKT/mTOR axis, frequently activated in ER-positive and HER2-positive breast cancers, promotes PD-L1 expression through downstream activation of NF-κB and STAT3. Similarly, EGFR signaling induces PD-L1 via MAPK and STAT3-dependent pathways, especially in TNBC. Inhibiting EGFR or downstream kinases reduces PD-L1 levels, supporting the rationale for combination therapies. Moreover, Wnt/β-catenin signaling—a pathway implicated in cancer stemness—has been linked to PD-L1 upregulation in basal-like TNBC, where activation of canonical Wnt signaling increases PD-L1 expression and enhances tumor cell survival.F2R Antibody Autophagy

Interferons, particularly IFN-γ, are potent inducers of PD-L1 expression.E2F-1 Antibody Technical Information Secreted by activated T cells and NK cells within the tumor microenvironment, IFN-γ signals through JAK1/JAK2 and phosphorylates STAT1/STAT2 dimers, which translocate to the nucleus and bind to interferon-stimulated response elements (ISREs) in the PD-L1 promoter.PMID:33956935 This pathway explains why PD-L1 is often found in high-TIL environments. However, chronic exposure to IFN-γ may lead to feedback inhibition and adaptive resistance, highlighting the need for timely intervention.

Emerging evidence also implicates non-coding RNAs and exosomal trafficking in PD-L1 regulation. MicroRNAs such as miR-513a-3p and miR-200c directly target PD-L1 mRNA, reducing its expression. Conversely, dysregulated miRNAs in breast cancer can derepress PD-L1. Furthermore, tumor-derived exosomes carrying PD-L1 can suppress T-cell function systemically, even in the absence of direct tumor-immune contact. These findings underscore the importance of considering both cellular and paracrine mechanisms in therapeutic design.

Therapeutically, targeting these regulatory pathways offers promising strategies. Combining immune checkpoint inhibitors with agents that modulate PD-L1 expression—such as PARP inhibitors (in BRCA-mutated tumors), HDAC inhibitors, or Wnt antagonists—may overcome resistance and enhance anti-tumor immunity. Preclinical models demonstrate that atezolizumab synergizes with FAK inhibitors or proteasome blockers to induce apoptosis and reduce invasion in PD-L1-positive TNBC cells.

In summary, PD-L1 expression in breast cancer is not static but shaped by multiple intersecting molecular networks. Understanding these mechanisms provides a foundation for developing more effective, personalized immunotherapies. Future research must focus on identifying predictive biomarkers beyond PD-L1, elucidating spatial and temporal dynamics of immune modulation, and designing rational combination regimens to improve outcomes in breast cancer patients.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

The pursuit of advanced optical materials with ultrafast and tunable nonlinear optical (NLO) responses across a wide spectral range has long been a central goal in photonics and optoelectronics. In this work, we report the synthesis and comprehensive characterization of a novel ether-linked porphyrin covalent organic framework (COF-Pors), which exhibits exceptional broadband NLO switching behavior from the visible to the near-infrared region. By integrating highly conjugated porphyrin units via robust ether linkages, we successfully constructed a two-dimensional crystalline framework with a well-defined porous architecture and high structural order. This material demonstrates a unique intensity-dependent transition between saturable absorption (SA) and reverse saturable absorption (RSA), enabling dynamic control over light transmission—key for applications in optical limiting, signal processing, and intelligent photonic devices.

Structural analysis confirmed the successful formation of ether bonds through a nucleophilic aromatic substitution reaction between fluorinated and hydroxylated porphyrin precursors. Fourier-transform infrared (FT-IR) spectroscopy showed the disappearance of the C–F stretch at 1091 cm⁻¹ and the appearance of a new peak at ~1011 cm⁻¹ attributed to C–O stretching, indicating covalent bond formation. X-ray photoelectron spectroscopy (XPS) revealed no detectable F1s signal in COF-Pors, confirming complete removal of fluorine atoms during polymerization. Solid-state ¹³C CP-MAS NMR displayed distinct peaks corresponding to carbon atoms in ether linkages, further supporting the proposed molecular structure. Powder X-ray diffraction (PXRD) and 2D small-angle X-ray scattering (SAXS) patterns exhibited sharp, symmetric diffraction rings, consistent with a highly ordered crystalline phase with eclipsed stacking. High-resolution transmission electron microscopy (HR-TEM) images revealed a square-lattice arrangement with lattice distances of approximately 0.24 nm and 0.28 nm, matching the predicted interlayer spacing.

Nitrogen adsorption-desorption measurements at 77 K demonstrated microporous characteristics, with a BET surface area of ~101 m²/g.DCK Antibody site The pore size distribution curve displayed a dominant peak at 1.8 nm, closely aligning with the theoretical pore aperture derived from the crystal model. Thermogravimetric analysis (TGA) indicated good thermal stability, with decomposition onset at ~382 °C in air and a weight loss of 13.86 wt.% at that temperature. Electron paramagnetic resonance (EPR) spectra revealed a g-value of 2.0034 under ambient conditions, which shifted slightly to 2.0037 under 532 nm laser irradiation, suggesting light-induced generation of unpaired electrons—consistent with excited-state population and radical formation mechanisms.

UV-Vis absorption spectroscopy revealed strong B-band absorption at 410–430 nm and Q-bands in the 500–700 nm range. The B-band maximum shifted to 430 nm in COF-Pors compared to its precursors, reflecting enhanced π-conjugation due to extended planar stacking. Ultraviolet photoelectron spectroscopy (UPS) enabled precise determination of electronic energy levels: the HOMO was located at −6.02 eV and the LUMO at −3.23 eV, yielding an optical bandgap of ~2.79 eV. These values are comparable to those of g-C₃N₄, suggesting similar potential for photocatalytic and optoelectronic applications. The calculated electrochemical potentials indicate favorable thermodynamic conditions for both hydrogen evolution and CO₂ reduction reactions.

Nonlinear optical properties were evaluated using open-aperture Z-scan measurements with 6 ns pulses at 532 nm and 1064 nm. At low excitation energies (40 mJ), COF-Pors exhibited symmetric transmittance minima with Tmin values of ~18.4% (532 nm) and ~12.6% (1064 nm), characteristic of SA behavior. As incident pulse energy increased beyond 70 mJ (532 nm) or 150 mJ (1064 nm), RSA became dominant, and Tmin dropped significantly—reaching as low as 0.64 at 300 mJ (532 nm) and 0.83 at 300 mJ (1064 nm). This reversible SA-to-RSA transition was fully reproducible and stable over multiple cycles. Notably, neither the fluorinated nor hydroxylated porphyrin precursor showed any measurable NLO response at 1064 nm, underscoring the critical role of the extended covalent network in enabling broadband functionality.

At 532 nm, where photon energy (~2.33 eV) is below the bandgap (~2.79 eV), ground-state bleaching dominates at low intensities, leading to SA. With increasing intensity, multi-photon absorption populates higher-energy excited states, resulting in RSA.PTPRF Antibody custom synthesis At 1064 nm, the photon energy (~1.PMID:34212433 17 eV) is insufficient for direct bandgap excitation, yet strong NLO response persists due to thermally induced nonlinear scattering (NLS). Heat transfer from COF-Pors to DMF solvent generates transient microbubbles and plasma domains, causing significant optical scattering and absorption. The high heat capacity and low thermal conductivity of DMF amplify this effect, enhancing optical limiting performance.

This study establishes COF-Pors as a pioneering example of ether-linked COFs with superior broadband NLO switching capabilities. Its ability to switch dynamically between SA and RSA modes enables versatile applications in all-optical logic circuits, ultrafast optical switches, and protective coatings for sensitive optical systems. The design strategy—leveraging ether linkages to stabilize large conjugated frameworks—opens a new frontier in COF chemistry. Future research should focus on solid-state integration, device fabrication, and fine-tuning of linker geometry to optimize charge transport and NLO efficiency. Ultimately, this work paves the way for next-generation smart photonic materials based on tailored covalent organic frameworks.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

Layered transition metal oxides have emerged as promising candidates for potassium-ion (KIB) and sodium-ion (NIB) battery cathodes due to their high theoretical capacities, suitable working potentials, and scalable synthesis routes. However, challenges such as structural degradation, sluggish ion kinetics, and high material cost hinder their practical application. This study presents a low-cost, environmentally benign, and structurally stable P3-type layered oxide, K₀.₄Fe₀.₁Mn₀.₈Ti₀.₁O₂, designed through strategic doping with abundant and non-toxic elements—iron and titanium. The material exhibits exceptional electrochemical performance for both potassium and sodium storage. In potassium half-cells, it delivers a reversible capacity of 117 mA h g⁻¹ at 20 mA g⁻¹ and maintains 71 mA h g⁻¹ even at 1000 mA g⁻¹, demonstrating outstanding rate capability. In situ X-ray diffraction confirms a solid-solution reaction mechanism with negligible volume change (only 0.5%), indicating true zero-strain behavior during cycling. This structural stability ensures excellent long-term cycling performance, retaining 74% capacity after 300 cycles at 200 mA g⁻¹. When applied in sodium-ion batteries, the material undergoes spontaneous ion exchange with Na⁺-containing electrolytes, forming K₀.PRKAA1 Antibody Formula ₁₂Na₀.HRAS Antibody Epigenetic Reader Domain ₂₈Fe₀.PMID:33863856 ₁Mn₀.₈Ti₀.₁O₂. The residual K⁺ ions act as structural pillars, stabilizing the layered framework and expanding interlayer spacing, which facilitates fast Na⁺ diffusion. As a result, the modified electrode achieves a high reversible sodium storage capacity of 160 mA h g⁻¹ and retains 81% of its initial capacity after 300 cycles. Moreover, the Na⁺ diffusion coefficient is enhanced to 10⁻¹¹–10⁻⁹ cm² s⁻¹, confirming improved ionic kinetics. These findings highlight the dual functionality of the material and provide a new design strategy for developing high-performance, low-cost cathodes for next-generation energy storage systems.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

Metal-organic frameworks (MOFs) have emerged as a promising class of microporous materials due to their high surface area, tunable pore size, and versatile functionality. These properties make them ideal candidates for solid-phase microextraction (SPME) coatings, particularly for the enrichment of trace volatile organic compounds (VOCs) in complex biological matrices such as exhaled breath. However, conventional MOF-based SPME coatings are predominantly derived from single-linker structures, limiting their ability to simultaneously enrich both polar and nonpolar analytes. This restriction arises because the selectivity of these coatings is primarily governed by the polarity of the linker molecules, which restricts their applicability in real-world samples with diverse chemical profiles. To overcome this limitation, we developed a hybrid Zeolitic Imidazolate Framework-8-90 (ZIF-8-90) coating on etched stainless steel fibers using a sol-gel method.PEG10 Antibody Autophagy ZIF-8-90 is constructed from a mixture of 2-methylimidazole (2-MeIM) and imidazolate-2-carboxyaldehyde (OHC-IM) linkers coordinated with Zn²⁺ ions, resulting in a framework that incorporates both methyl and aldehyde functional groups. This dual functionality enables synergistic interactions with a wide range of VOCs, including hydrophilic (ethanol, acetone, hexanol, hexanal) and hydrophobic (nonane, heptane, decane, isoprene) biomarkers.

The fabricated ZIF-8-90-coated fiber demonstrated excellent extraction performance across all eight target analytes. It exhibited high enrichment efficiency, broad linear dynamic range (three orders of magnitude), and low detection limits ranging from 0.82 to 2.64 μg L⁻¹. The relative standard deviation (RSD) for six consecutive extractions using the same fiber was between 2.5% and 7.3%, indicating outstanding repeatability. Inter-fiber reproducibility among three independently prepared fibers ranged from 4.8% to 12.0% (RSD), confirming good batch-to-batch consistency. Notably, the fiber maintained its performance over at least 120 extraction-desorption-conditioning cycles without significant loss in sensitivity or precision, highlighting its robustness and long service life.Neurogenin 3 Antibody In Vivo The enhanced performance is attributed to the combined effects of the methyl groups (favoring hydrophobic interactions) and aldehyde groups (capable of hydrogen bonding with polar species), along with the well-defined microporous structure of ZIF-8-90 (pore size ~4–5 Å), which allows efficient diffusion and adsorption of small molecule analytes.PMID:35078977

The method was successfully applied to real exhaled breath samples collected from six gastric cancer patients and six healthy volunteers. Quantitative analysis revealed significantly elevated levels of ethanol, acetone, hexanal, hexanol, nonane, and decane in cancer patients compared to controls, while isoprene levels were relatively lower. Recovery studies using spiked standards showed recoveries between 88% and 106%, confirming the accuracy and reliability of the method. In comparison to commercial PDMS and PA fibers, as well as single-linker ZIF-8 and ZIF-90 coatings, the ZIF-8-90-coated fiber consistently outperformed all others in terms of enrichment capacity for both polar and nonpolar targets. This work establishes a new paradigm for designing multifunctional MOF coatings through rational hybridization, offering a powerful tool for non-invasive, early-stage diagnosis of gastric cancer via breath analysis.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

Inherited atherogenic dyslipidemias represent a group of monogenic disorders characterized by elevated levels of atherogenic lipoproteins, significantly increasing the risk of premature atherosclerotic cardiovascular disease (ASCVD). These conditions—familial hypercholesterolemia (FH), familial combined hyperlipidemia (FCHL), and familial primary hypoalphalipoproteinemia (FHA)—are formally recognized in the International Classification of Diseases (ICD) and extensively documented in clinical literature. Despite their well-established pathophysiology and significant public health impact, these disorders remain grossly underdiagnosed in routine clinical settings. Epidemiological data suggest that FH alone affects approximately 1 in 250 individuals globally, with prevalence rising to as high as 75% among patients with early-onset ASCVD under the age of 65.FAK Antibody Biological Activity However, real-world clinical practice reveals a stark contrast: diagnostic codes for inherited atherogenic dyslipidemias are rarely recorded in medical records.CD38 Antibody Technical Information

A recent analysis of hospital discharge records from Pisa, Italy, covering over 61,000 admissions across four years, found that only 5.PMID:35129075 4% of patients were assigned an inherited atherogenic dyslipidemia code—most frequently as a secondary diagnosis. Among those admitted for ASCVD (n = 31,380), this figure rose slightly to 9%. In the subset of patients under 65 years of age (n = 13,221), only 9.2% carried such a diagnosis, far below the expected rate. This discrepancy underscores a systemic failure in identifying and coding these high-risk conditions. The reasons likely include time constraints during acute hospitalizations, particularly for acute coronary syndromes (ACS), where clinicians prioritize immediate life-saving interventions over long-term genetic risk assessment. As a result, patients are often discharged without a formal diagnosis or referral for cascade screening.

The economic implications are substantial. Patients with both ASCVD and inherited atherogenic dyslipidemia incurred average costs more than double those without the diagnosis—€15,285 versus €5,699—highlighting the increased burden associated with undiagnosed disease. Moreover, the growing use of expensive therapies such as PCSK9 inhibitors and lomitapide in patients who may not meet diagnostic criteria raises concerns about healthcare sustainability. Without accurate diagnosis, treatment becomes reactive rather than preventive, undermining the potential benefits of early intervention.

To address this gap, it is imperative to integrate the diagnosis of inherited atherogenic dyslipidemia into quality-of-care indicators for ACS and myocardial infarction management. Public health authorities must support standardized diagnostic pathways, promote awareness among physicians, and invest in population-based screening strategies. Only through systematic identification can we ensure timely initiation of statin therapy, cascade family screening, and effective secondary prevention—ultimately reducing the global burden of premature cardiovascular disease.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

Liver fibrosis, a progressive pathological condition triggered by chronic liver injury, often leads to cirrhosis and hepatocellular carcinoma if left untreated. Early diagnosis is critical for effective intervention and improved patient outcomes. However, current diagnostic methods such as liver biopsy are invasive, carry risks of complications, and lack repeatability. Non-invasive imaging techniques like ultrasound and CT suffer from poor sensitivity and specificity in detecting early-stage fibrosis. Therefore, there is an urgent need for accurate, non-invasive, and real-time diagnostic tools.

Monoamine oxidase B (MAO-B), a flavin-dependent enzyme overexpressed in early-stage liver fibrosis, has emerged as a promising biomarker. Its elevated activity correlates with hepatic stellate cell activation and excessive collagen deposition—hallmarks of fibrogenesis. Despite its potential, existing detection strategies for MAO-B are limited by slow reaction kinetics, low sensitivity, or poor spatial resolution, hindering their clinical utility.ANXA5 Antibody Purity

To address these challenges, we developed a novel two-photon fluorescence imaging platform based on a simple, rationally designed probe named BiPhAA. This probe consists of a benzylamine moiety linked to 2-aminobenzeneboronic acid via Suzuki coupling. Upon exposure to MAO-B, the benzylamine group is specifically oxidized to an aldehyde, which then reacts intramolecularly with the adjacent amino group to form a conjugated imine system. This structural transformation dramatically enhances fluorescence emission at 520 nm under 490 nm excitation, resulting in a bright turn-on signal within just 10 minutes—making it significantly faster than previously reported probes that require up to 2 hours.

The probe exhibits high selectivity for MAO-B over other enzymes, amino acids, metal ions, and reactive oxygen species, as confirmed through extensive control experiments. In vitro assays demonstrated a linear response to MAO-B concentrations ranging from 0 to 2.0 ng/L, with a detection limit as low as 0.02 ng/L. Moreover, BiPhAA showed excellent photostability and minimal cytotoxicity in both LX-2 hepatic stellate cells and HL7702 hepatocytes, indicating strong biocompatibility.hnRNP U Antibody Purity & Documentation

We further validated the probe’s performance in living cells using two-photon microscopy.PMID:35143137 Real-time imaging revealed a significant increase in fluorescence intensity in control cells incubated with BiPhAA, while pretreatment with the selective inhibitor D-penicillamine drastically reduced signal output. These results were corroborated by enzyme activity assays, confirming that fluorescence changes directly reflect MAO-B activity.

In vivo applications were conducted using a carbon tetrachloride (CCl₄)-induced mouse model of liver fibrosis. After tail vein injection of BiPhAA, two-photon imaging of deep liver tissues showed approximately six-fold higher fluorescence intensity in fibrotic mice compared to normal controls. The signal was effectively suppressed in mice pre-treated with D-penicillamine, confirming the specificity of the probe. Additionally, ex vivo imaging using the IVIS system confirmed the same trend, with strong fluorescence in fibrotic livers and weak signals in inhibitor-treated samples.

These findings demonstrate that BiPhAA enables rapid, sensitive, and specific two-photon fluorescence imaging of endogenous MAO-B activity in live animals. Its ability to distinguish early-stage liver fibrosis from normal tissue in real time offers a powerful tool for non-invasive diagnosis. By visualizing MAO-B dynamics in situ, this method not only facilitates early detection but also provides insights into the molecular mechanisms underlying liver fibrosis progression. We believe BiPhAA holds great promise for future translation into clinical diagnostics and therapeutic monitoring.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com